Genovese Burford & Brothers Wealth & Retirement Plan Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Genovese Burford & Brothers Wealth & Retirement Plan Management's PFE Position: Q4 2020 in Review
Genovese Burford & Brothers Wealth & Retirement Plan Management reduced its Pfizer (PFE) stake by 2.6% in Q4 2020, selling an estimated $10.1K and leaving 10,471 shares worth $385K. The position accounts for 0.1% of the portfolio, ranked #75.
Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in PFE in Q4 2015 and has held it in 20 quarters since. The position peaked at $652K in Q4 2018. 2,675 funds tracked by Wall St. Rank hold PFE as of Q4 2020.
- Genovese Burford & Brothers Wealth & Retirement Plan Management held 10,471 shares of Pfizer worth $385K as of Q4 2020.
- Genovese Burford & Brothers Wealth & Retirement Plan Management sold 275 Pfizer shares in Q4 2020, an estimated $10.1K.
- Pfizer made up 0.1% of Genovese Burford & Brothers Wealth & Retirement Plan Management's portfolio in Q4 2020, its #75 holding.
- Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Pfizer in Q4 2015 and has held it in 20 quarters since.
- Genovese Burford & Brothers Wealth & Retirement Plan Management's Pfizer position peaked at $652K in Q4 2018.
- 2,675 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.
Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q4 2020, filed 5 Feb 2021.